Skip to main navigation
Centessa Pharmaceuticals
  • About Us
  • Team
  • Programs and Pipeline
    • Summary and Pipeline
    • Orexin Receptor 2 Agonist Program
    • LockBody® Technology Platform
  • Patients
  • Investors
  • News
  • Careers
  • About Us
  • Team
  • Programs and Pipeline
    • Summary and Pipeline
    • Orexin Receptor 2 Agonist Program
    • LockBody® Technology Platform
  • Patients
  • Investors
  • News
  • Careers
Centessa Pharmaceuticals
  • About Us
  • Team
  • Programs and Pipeline
    • Summary and Pipeline
    • Orexin Receptor 2 Agonist Program
    • LockBody® Technology Platform
  • Patients
  • Investors
  • News
  • Careers
Centessa Pharmaceuticals
  • About Us
  • Team
  • Programs and Pipeline
    • Summary and Pipeline
    • Orexin Receptor 2 Agonist Program
    • LockBody® Technology Platform
  • Patients
  • Investors
  • News
  • Careers
  • About Us
  • Team
  • Programs and Pipeline
    • Summary and Pipeline
    • Orexin Receptor 2 Agonist Program
    • LockBody® Technology Platform
  • Patients
  • Investors
  • News
  • Careers
Centessa Pharmaceuticals
  • About Us
  • Team
  • Programs and Pipeline
    • Summary and Pipeline
    • Orexin Receptor 2 Agonist Program
    • LockBody® Technology Platform
  • Patients
  • Investors
  • News
  • Careers
  • Overview
  • Press Releases
  • Events & Presentations
  • Financials
    SEC Filings Annual Reports
  • Stock Info
    Stock Quote & Chart Historical Price Lookup Analyst Coverage
  • Governance
    Documents & Charters Management Team Board of Directors Committee Composition
  • Annual General Meeting
  • Shareholder Resources
    FAQs Email Alerts Contact Us RSS Feeds PFIC Information

Annual General Meeting

2025

2024 Annual Report on Form 10-K
Notice of Annual General Meeting and Proxy Statement
UK Notice of Annual General Meeting
Form of Proxy
2024 UK Annual Report and Accounts

2024

2023 Annual Report on Form 10-K
Notice of Annual General Meeting and Proxy Statement
UK Notice of Annual General Meeting
Form of Proxy
2023 UK Annual Report and Accounts

2023

2022 Annual Report on Form 10-K
Notice of Annual General Meeting and Proxy Statement
UK Notice of Annual General Meeting
Form of Proxy
2022 UK Annual Report and Accounts

2022

2021 Annual Report on Form 10-K
Notice of Annual General Meeting and Proxy Statement
Form of Proxy
2021 UK Annual Report and Accounts
Print Page
FAQs
Email Alerts
Contact Us
RSS Feeds

Centessa Pharmaceuticals
  • About Us
  • Team
  • Programs and Pipeline
  • Investors
  • News
  • Careers
Menu
  • About Us
  • Team
  • Programs and Pipeline
  • Investors
  • News
  • Careers
  • Privacy Notices
  • PFIC Information
Contact Us
Follow Us